On October 10, 2018, Robert Orbach, Café Serendipity Holdings, Inc., now known as BioQuest Corp.'s (the “Company”) sole director, appointed Thomas C. Hemingway and Michael Krall to the Company's Board of Directors (the “Board”) to fill vacancies. Effective October 10, 2018, the Board appointed Thomas C. Hemingway as the Company's Chief Executive Officer, Chief Financial and Accounting Officer and Secretary and Michael Krall as President. Mr. Hemingway, age 62, is Chairman and President of Redwood Investment Group and has served in that capacity since 1998.

Mr. Hemingway's experience is a combination of deep Wall Street relationships and real-life experience which has helped him successfully found and operate numerous public and private companies. Mr. Hemingway has served as an investor and board member of Force Fuels, Inc. as well as Chief Executive Officer and Chairman of Oxford Media, Inc. Michael Krall. Michael Krall, 66, is a retired executive since August 2013.

He was the founder of PURE Bioscience, Inc. From 1996 until August 2013, Mr. Krall served as PURE Bioscience's Chairman, President and CEO. Additionally, he is an inventor and co-inventor of dozens of biotech products. Mr. Krall brings a wealth of knowledge in the biotech, manufacturing and securities industries.